
Lipocine (LPCN) Market Capitalization Overview
Market Cap: $16.67M as of Jun 13, 2025
$16.67M
Past Month-$3.29M (16.48%)
As of Jun 13, 2025, Lipocine (LPCN) has a market capitalization of $16.67M. Over the past 30 days, its market cap has decreased by -7.87%, while in the last 12 months, it has decreased by -36.14%.
Market capitalization represents the total value of Lipocine as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Lipocine (LPCN) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Lipocine (LPCN) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Lipocine as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Lipocine (LPCN) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Lipocine (LPCN) helps investors assess the company's size and compare it with competitors for better investment decisions.
Lipocine (LPCN) Market Cap & Key Trends
See Lipocine’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Lipocine (LPCN)
Order type
Buy in
Order amount
Est. shares
0 shares
Lipocine (LPCN) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $17.55M | -7.87% |
May 1, 2025 | $19.05M | +6.43% |
Apr 1, 2025 | $17.90M | +11.18% |
Mar 3, 2025 | $16.10M | -30.96% |
Feb 3, 2025 | $23.32M | -10.29% |
Jan 2, 2025 | $25.99M | +13.02% |
Lipocine (LPCN) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $16.67M | -36.14% |
2024 | $26.10M | +75.97% |
2023 | $14.84M | -57.88% |
2022 | $35.21M | -59.76% |
2021 | $87.51M | -8.13% |
2020 | $95.25M | — |
FAQs About Lipocine (LPCN) Market Cap
As of Jun 13, 2025, the market capitalization of Lipocine (LPCN) is $16.67M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Lipocine’s market capitalization has decreased by -16.48%, changing from $19.96M to $16.67M as of Jun 13, 2025.
In the last 3 months, Lipocine’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Lipocine’s market capitalization increased from $14.84M in January to $26.10M in December, reflecting a 75.97% change.
In the past five years, Lipocine (LPCN) has had a compound annual growth rate (CAGR) of -22.81% in market capitalization. This means its market cap has shrunk at an average rate of -22.81% per year.